Abiomed expects revenue boost, but shy of forecast
The company's fiscal year ends March 31.
Abiomed said it expects revenue between $86 million and $91 million, marking a 17 percent to 25 percent boost over fiscal 2009 revenue of $73.2 million.
Analysts polled by Thomson Reuters expect revenue of $93.8 million, on average.
Last week, Abiomed reported fourth-quarter financial results that fell shy of Wall Street forecasts, though its loss narrowed on lower overall expenses. (AP)